New 51,000 sq. ft. paint facility being built adjacent to the service facility will extend Bombardier’s ongoing commitment to ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

In a comprehensive Genomic Press Interview published in Brain Medicine, Dr. Michael C. Oldham shares his unconventional journey from advertising executive to computational neuroscientist and his ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

The fourth fundamental circuit component that is frequently employed to design nanoscale electronic devices is memristor. The compact size, non-volatility, and low power of memristor, combined with ...

Experimental treatment could offer a safer, cheaper alternative to CAR-T-cell therapies for disorders such as lupus.

Israel has introduced requirements for PV system installations on all new non-residential buildings with rooftop areas above ...